|
US5783593A
(en)
*
|
1993-11-04 |
1998-07-21 |
Abbott Laboratories |
Inhibitors of squalene synthetase and protein farnesyltransferase
|
|
WO1999065897A1
(en)
*
|
1998-06-19 |
1999-12-23 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
|
DE60023492T2
(de)
|
1999-05-17 |
2006-07-20 |
Novo Nordisk A/S |
Glucagon antagonisten/inverse agonisten
|
|
DE19929787A1
(de)
*
|
1999-06-29 |
2001-01-04 |
Bayer Ag |
Neue 4-(2-Oxodihydrooxadiazinylphenyl)amide und ihre Verwendung
|
|
DE10060807A1
(de)
*
|
2000-12-07 |
2002-06-20 |
Aventis Pharma Gmbh |
Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
|
|
WO2002100833A1
(en)
|
2001-06-12 |
2002-12-19 |
Sumitomo Pharmaceuticals Company, Limited |
Rho KINASE INHIBITORS
|
|
CA2460541A1
(en)
*
|
2001-09-14 |
2003-04-03 |
Helle Birk Olsen |
Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer
|
|
GB0124936D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
US7119120B2
(en)
|
2001-12-26 |
2006-10-10 |
Genzyme Corporation |
Phosphate transport inhibitors
|
|
DK1603570T5
(da)
*
|
2003-02-26 |
2013-12-09 |
Sugen Inc |
Aminoheteroarylforbindelser som proteinkinaseinhibitorer
|
|
BRPI0408365B8
(pt)
|
2003-03-14 |
2021-05-25 |
Avidex Ltd |
compostos heterocíclicos de imunomodulação
|
|
WO2005000821A1
(en)
*
|
2003-06-12 |
2005-01-06 |
Eli Lilly And Company |
Tachykinin receptor antagonists
|
|
JP5017103B2
(ja)
|
2004-06-17 |
2012-09-05 |
トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド |
薬剤共結晶組成物および関連した使用方法
|
|
KR20070094754A
(ko)
|
2004-12-01 |
2007-09-21 |
데브젠 엔브이 |
이온 채널, 특히 Ｋｖ 패밀리로부터의 이온 채널과상호작용하는 5-카복사미도 치환된 티아졸 유도체
|
|
EP1838690A2
(en)
*
|
2004-12-21 |
2007-10-03 |
Devgen N.V. |
Compounds with kv4 ion channel activity
|
|
AU2006306542B2
(en)
*
|
2005-10-21 |
2012-04-19 |
Merck Sharp & Dohme Corp. |
Potassium channel inhibitors
|
|
DE102006005861A1
(de)
|
2006-02-09 |
2007-08-23 |
Aicuris Gmbh & Co. Kg |
Substituierte Chinolone III
|
|
CA2637620A1
(en)
*
|
2006-02-16 |
2007-08-30 |
Boehringer Ingelheim International Gmbh |
Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
|
|
US7601716B2
(en)
*
|
2006-05-01 |
2009-10-13 |
Cephalon, Inc. |
Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
|
JP2009536657A
(ja)
*
|
2006-05-10 |
2009-10-15 |
レノビス， インコーポレイテッド |
イオンチャンネルリガンドとしてのアミド誘導体およびそれを用いる医薬組成物および方法
|
|
WO2007138112A2
(en)
*
|
2006-06-01 |
2007-12-06 |
Devgen N.V. |
Compounds that interact with ion channels, in particular with ion channels from the kv family
|
|
WO2007138110A2
(en)
*
|
2006-06-01 |
2007-12-06 |
Devgen N.V. |
Compounds that interact with ion channels, in particular with ion channels from the kv family
|
|
ATE520651T1
(de)
*
|
2006-10-23 |
2011-09-15 |
Pfizer |
Substituierte phenylmethylbicyclocarbonsäureamidverbindungen
|
|
US7956216B2
(en)
*
|
2006-12-21 |
2011-06-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Alpha-helical mimetics
|
|
EP1995241B1
(en)
*
|
2007-03-23 |
2010-03-17 |
ICAgen, Inc. |
Inhibitors of ion channels
|
|
WO2009017838A2
(en)
|
2007-08-01 |
2009-02-05 |
Exelixis, Inc. |
Combinations of jak-2 inhibitors and other agents
|
|
EP2020413A1
(de)
|
2007-08-02 |
2009-02-04 |
Bayer CropScience AG |
Oxaspirocyclische-spiro-substituierte Tetram- und Tetronsäure-Derivate
|
|
ES2400604T3
(es)
|
2007-08-17 |
2013-04-11 |
Icagen, Inc. |
Heterociclos como moduladores del canal de potasio
|
|
DE102007044277A1
(de)
|
2007-09-17 |
2009-03-19 |
Grünenthal GmbH |
Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln
|
|
WO2009064449A1
(en)
|
2007-11-13 |
2009-05-22 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
WO2009117421A2
(en)
*
|
2008-03-17 |
2009-09-24 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
TW201004939A
(en)
*
|
2008-04-17 |
2010-02-01 |
Glaxo Group Ltd |
Novel compounds
|
|
TW201000447A
(en)
*
|
2008-05-30 |
2010-01-01 |
Astrazeneca Ab |
New compounds useful in pain therapy
|
|
TW201000446A
(en)
*
|
2008-05-30 |
2010-01-01 |
Astrazeneca Ab |
New compounds useful in pain therapy
|
|
PE20100083A1
(es)
*
|
2008-06-05 |
2010-02-17 |
Janssen Pharmaceutica Nv |
Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar
|
|
CA2751534A1
(en)
*
|
2009-03-03 |
2010-09-10 |
Pfizer Inc. |
Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators
|
|
TWI475020B
(zh)
|
2009-03-12 |
2015-03-01 |
|
The substituted nicotine amide as a KCNQ2 / 3 modifier
|
|
TWI461197B
(zh)
*
|
2009-03-12 |
2014-11-21 |
|
2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
|
|
WO2011021645A1
(ja)
*
|
2009-08-19 |
2011-02-24 |
大日本住友製薬株式会社 |
２環性ウレア誘導体、またはその薬学的に許容される塩
|
|
JP2013028538A
(ja)
*
|
2009-11-13 |
2013-02-07 |
Dainippon Sumitomo Pharma Co Ltd |
新規アミド誘導体
|
|
CN103249721B
(zh)
*
|
2010-10-18 |
2016-10-12 |
拉夸里亚创药株式会社 |
作为ttx-s阻滞剂的芳胺衍生物
|
|
DE102011101446A1
(de)
*
|
2011-05-10 |
2012-11-15 |
Aicuris Gmbh & Co. Kg |
Herstellung von "Dense Bodies" (DB)
|
|
JP6007417B2
(ja)
*
|
2011-05-31 |
2016-10-12 |
レセプトス エルエルシー |
新規ｇｌｐ−１受容体安定剤および調節剤
|
|
KR101476379B1
(ko)
|
2011-11-30 |
2014-12-29 |
한국과학기술연구원 |
페녹시프로판올 유도체 및 이를 함유하는 약학적 조성물
|
|
CA2860022A1
(fr)
|
2011-12-30 |
2013-07-04 |
Universite D'auvergne Clermont I |
Composes anti-douleur
|
|
WO2013156155A1
(en)
|
2012-04-18 |
2013-10-24 |
Grünenthal GmbH |
Substituted 4-aminobenzamides as kcnq2/3 modulators
|
|
AR094929A1
(es)
*
|
2013-02-28 |
2015-09-09 |
Bristol Myers Squibb Co |
Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
|
|
JPWO2015012328A1
(ja)
|
2013-07-24 |
2017-03-02 |
武田薬品工業株式会社 |
複素環化合物
|
|
JP2017114765A
(ja)
|
2014-04-25 |
2017-06-29 |
大正製薬株式会社 |
トリアゾリルで置換されたヘテロアリール化合物
|
|
CN106414429B
(zh)
|
2014-06-03 |
2020-01-03 |
爱杜西亚药品有限公司 |
吡唑化合物及其作为t型钙通道阻断剂的用途
|
|
AU2015283850B2
(en)
*
|
2014-07-03 |
2020-06-04 |
Board Of Regents, University Of Texas System |
GLS1 inhibitors for treating disease
|